Dhiti Bioscience Diagnostic Technology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Profit 33.30%
(FY 2020)
- Ebitda 33.30%
(FY 2020)
- Net Worth -29.12%
(FY 2020)
- Total Assets -21.42%
(FY 2020)
About Dhiti Bioscience Diagnostic Technology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sumeet Dhingra, Anand Sekhri, and Naresh Singh serve as directors at the Company.
- CIN/LLPIN
U33309DL2017PTC319682
- Company No.
319682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2017
- Date of AGM
29 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dhiti Bioscience Diagnostic Technology?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumeet Dhingra  | Director | 02-Nov-2017 | Current |
| Anand Sekhri | Director | 23-Jun-2017 | Current |
| Naresh Singh | Director | 23-Jun-2017 | Current |
Financial Performance of Dhiti Bioscience Diagnostic Technology.
Dhiti Bioscience Diagnostic Technology Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 33.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 29.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhiti Bioscience Diagnostic Technology?
In 2020, Dhiti Bioscience Diagnostic Technology had a promoter holding of 0.10% and a public holding of 99.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dhiti Diagnostics Private LimitedActive 8 years 6 monthsSumeet Dhingra and Anand Sekhri are mutual person
- Dhiti Healthcare Private LimitedActive 8 years 5 months
Sumeet Dhingra, Anand Sekhri and 1 more are mutual person
- Veexl Surface Engineering Private LimitedActive 14 years 7 months
Sumeet Dhingra and Anand Sekhri are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dhiti Bioscience Diagnostic Technology?
Unlock and access historical data on people associated with Dhiti Bioscience Diagnostic Technology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhiti Bioscience Diagnostic Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhiti Bioscience Diagnostic Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
